已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects

茚达特罗 糠酸莫米松 医学 交叉研究 药代动力学 皮质类固醇 药理学 最大值 内科学 麻醉 哮喘 支气管扩张剂 安慰剂 病理 替代医学
作者
Soniya Vaidya,Sanjeev Khindri,Nicole Calder,Surendra Machineni,Hisanori Hara,Tapan Majumdar,Salvatore Febbraro,Rainard Fuhr,Ralph Woessner
出处
期刊:Pulmonary Pharmacology & Therapeutics [Elsevier BV]
卷期号:37: 30-36 被引量:17
标识
DOI:10.1016/j.pupt.2016.01.004
摘要

QMF149 is a fixed-dose combination of the long-acting β2 agonist, indacaterol and the corticosteroid, mometasone furoate that is currently under development for treatment of patients with asthma and chronic obstructive pulmonary disease. We describe here a study designed to assess any pharmacokinetic (PK) and/or biopharmaceutical interaction between indacaterol and mometasone furoate when administered via the Breezhaler(®) device, either alone or in a free or fixed combination (QMF149) in healthy adult subjects.In this randomized, open-label, four-way crossover study, subjects were randomized to receive indacaterol acetate 150 μg, mometasone furoate 320 μg, alone and as free combination of the individual components, or QMF149 (indacaterol acetate 150 μg/mometasone furoate 320 μg) once daily for 14 days in each period, followed by a 7-day washout between periods. PK profiles were characterized on Day 14 up to 168 h post-dose.Indacaterol AUC0-24h,ss and Cmax,ss after administration of QMF149 were 13% [ratio: 1.13; 90%CI: 1.09, 1.17] and 18% [ratio: 1.18; 90%CI: 1.12, 1.25] higher, respectively, than indacaterol monotherapy. Mometasone furoate AUC0-24h,ss and Cmax,ss after administration of QMF149 were 14% [ratio: 1.14; 90%CI: 1.09, 1.20] and 19% [ratio: 1.19; 90%CI: 1.13, 1.26], higher, respectively than mometasone furoate monotherapy. The majority (three of four comparisons between QMF149 and monotherapy) of the 90% confidence intervals of the between-treatment ratios for AUC0-24h,ss and Cmax,ss were within the 0.80 to 1.25 interval and therefore fulfilled bioequivalence criteria. The 90% confidence interval for Cmax,ss for MF for the QMF149 vs. monotherapy comparison was [1.13, 1.26]. Although no definitive data can be provided on the basis of the present study results, it is unlikely that the small observed differences in expsoure are clinically meaningful. Multiple inhaled doses of indacaterol and mometasone furoate, when administered alone, in free combination or as QMF149 were well tolerated.The QMF149 fixed dose combination treatment showed comparable systemic exposure to the free combination and monotherapy treatments in terms of AUC0-24h,ss and Cmax,ss for both indacaterol and mometasone furoate, indicating an absence of clinically relevant PK or biopharmaceutical interactions. These data support further development of QMF149 without dose adjustment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
leeeeeeee完成签到 ,获得积分20
1秒前
温暖忆山完成签到,获得积分20
1秒前
小陀螺完成签到 ,获得积分10
1秒前
马达发布了新的文献求助20
1秒前
1秒前
1秒前
2秒前
none发布了新的文献求助10
4秒前
1234发布了新的文献求助10
5秒前
nini完成签到,获得积分10
5秒前
5秒前
南城发布了新的文献求助10
5秒前
阿宁完成签到 ,获得积分10
5秒前
爆米花的应助被Waitcy采纳,获得10
6秒前
6秒前
Rina发布了新的文献求助10
7秒前
liuxi12138完成签到,获得积分10
7秒前
9秒前
一锅炖不下完成签到,获得积分20
11秒前
xcgh给法就的求助进行了留言
11秒前
YBadada完成签到,获得积分10
12秒前
unik完成签到,获得积分10
12秒前
潘森爱科研完成签到,获得积分10
13秒前
Jane发布了新的文献求助10
13秒前
领导范儿的应助被LIUDAN采纳,获得10
16秒前
ralph_liu完成签到,获得积分10
16秒前
16秒前
cnspower的应助被JiuJiu采纳,获得30
17秒前
格物致知完成签到,获得积分10
17秒前
SciGPT的应助被hejiacheng采纳,获得50
18秒前
英俊的铭的应助被Rina采纳,获得10
18秒前
Owen的应助被Jane采纳,获得10
18秒前
Tori发布了新的文献求助50
18秒前
19秒前
某个不想做人的dio完成签到,获得积分10
20秒前
20秒前
shenxian82133发布了新的文献求助10
20秒前
21秒前
Maestro_S的应助被nuodei采纳,获得10
22秒前
是驼驼呀完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194612
求助须知:如何正确求助?哪些是违规求助? 9580394
关于积分的说明 21870930
捐赠科研通 7794182
什么是DOI,文献DOI怎么找? 3437711
关于科研通互助平台的介绍 2561001
邀请新用户注册赠送积分活动 2484411